Yes. Language recovery follows the same 3–6 month golden period as motor recovery. Aphasia and dysarthria respond best to daily, high-repetition speech therapy started as early as the patient is medically stable. Most families notice the first changes — short words, following simple commands — within 2–4 weeks of intensive training.

• •Daily speech sessions combined with physical and occupational therapy
• •Melodic Intonation Therapy (MIT) and Constraint-Induced Language Therapy (CILT)
• •Oral-motor and swallowing training for patients on a feeding tube
• •AAC communication boards while verbal output is still limited

Some physicians prescribe Cerebrolysin as an adjunct alongside speech therapy after stroke, and a number of studies have looked at language outcomes. The evidence is not conclusive, and no medication replaces structured speech-language therapy. Whether it is suitable is a decision for the attending physician after reviewing the patient's case.

When a physician decides to use it, it is usually started once the patient is medically stable and still inside the 3–6 month golden period, as an intravenous course of roughly 10–21 days. It is always combined with daily speech-language therapy — the benefits reported in studies come from the combination, not from the drug alone — and progress is judged on measurable language and communication gains.

Physicians most often consider it for ischaemic stroke patients in the early window with moderate-to-severe language impairment, or traumatic brain injury patients with additional cognitive deficits. It is avoided or used with caution in severe renal impairment, epilepsy and known hypersensitivity. Side effects are usually mild — dizziness, palpitations, flushing — and increase with rapid infusion. At Sanpiti it is given only on the attending physician's order under 24-hour nursing supervision and billed separately from therapy fees.